Current status: 938 hESC lines, 5050 hiPSC lines, and 126 clinical studies, and 1739 certificates
Monthly statistic from Oct 1, 2023
Posted on October 1, 2023
| total lines | 5988 |
| hESC lines | 938 |
| hiPSC lines | 5050 |
| derivation countries | 46 |
| projects | 277 |
| providers | 843 |
| clinical studies | 126 |
| subclones | 2362 |
| certificates | 1739 |
| cell line certificates | 1598 |
| project certificates | 141 |